Patents by Inventor Felix VAURA

Felix VAURA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CLEVER-1 AGENTS FOR CONTROLLING THE EXPRESSION OF CELL SURFACE MARKERS ON LEUCOCYTES, AND USING THESE TO GUIDE ANTI-CLEVER-1 BASED CANCER TREATMENT
    Publication number: 20220404366
    Abstract: A method for monitoring a patient's response to anti-Clever-1 therapy and estimating the need for combination therapy based on the expression levels of one or more cell surface marker selected from PD-1, PD-L1, CTLA-4, ICOS, OX40, 41BB, LAG3, TIM3, CD28, CD25 and CXCR3 on leucocytes in relation to anti-Clever-1 treatment and choosing the best combination agent to initiate treatment together with anti-Clever-1 therapy after observed changes in one or more cell surface marker expression.
    Type: Application
    Filed: November 10, 2020
    Publication date: December 22, 2022
    Applicant: Faron Pharmaceuticals Oy
    Inventors: Maija-Leena HOLLMÉN, Reetta VIRTAKOIVU, Felix VAURA, Juho JALKANEN, Jami MANDELIN